Clinical TrialsSearch results
Number of results: 757
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Phase III Clinical Study on Taste Disorder by Z-103
-Double Blind Comparison Study on Patients with Zinc-Deficient and Idiopathic Taste Disorders -
- Zinc-Deficient and Idiopathic Taste Disorders
- ZERIA Pharmaceutical Co.,Ltd.
- 2006-04-10
Other
- Immediate cooling of the brain during the resuscitation period by the use of a pharyngeal cooling device
- Witnessed cardiac arrest(except cardiac arrest due to trauma)
- Okayama University Medical School
- 2009-07-31
Completed
- A Relative Bioavailability and Food Effect Trial of OPC-131461 in Healthy Adult Male Subjects
- Volume overload in heart failure
- Matsumaru Takehisa
- 2021-11-12
Completed
- Single and Multiple Oral Dose Trial of OPC-131461 in Healthy Adult Male Subjects
- Volume overload in heart failure
- Kim Seongryul
- 2020-12-07
Other
- Post-marketing clinical study of TALYMUS ophthalmic suspension 0.1% (tacrolimus) in vernal keratoconjunctivitis
- Vernal keratoconjunctivitis
- Senju Pharmaceutical Co., Ltd.
- 2008-09-01
Other
- Clinical study of Prevention and Actual situation of Venous Thromboembolism after Total Arthroplasty
- Venous Thromboembolism Osteoarthrosis
- National Hospital Organization
- 2008-09-11
Completed
- A study to learn how safe elinzanetant is, how it affects the body, and how it moves into, through and out of the body after single and multiple doses in Japanese healthy female adults
- Vasomotor Symptoms as a sex-hormone dependent disorder in women and men
- Myoishi Masashi
- 2021-07-30
Other
- An Open-label Study of SI-449 in Patients Undergoing Laparoscopic Uterine Myomectomy.
- Uterine myoma
- Sagawa Kenji
- 2021-12-23
Other
- A Randomized Phase III trial of Paclitaxel plus Cisplatin versus Paclitaxel plus Carboplatin in Stage IVB, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)
- uterine cervical neoplasms
- Japan Clinical Oncology Group(JCOG)
- 2006-02-21
Other
- Phase II clinical trial of personalized peptide vaccination in patients with advanced/metastatic urotherial cancer failed to standard treatment
- Urotherial cancer
- Kurume University School of medicine, Department of Immunology
- 2009-04-10